Silvia Regina Cavani Jorge Santos

Prof. Silvia Regina Cavani Jorge Santos

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2010 in Clinics
Verified
Journal Article
Open access
PDF file
Silvia Regina Cavani Jorge SantosSilvia Regina Cavani Jorge Santos
Silvia Regina Cavani Jorge Santos
ECEdvaldo Vieira Campos
Edvaldo Vieira Campos
CSCristina Sancehs
Cristina Sancehs
DGDavid Souza Gomez
David Souza Gomez
MFMarcus Castro Ferreira
Marcus Castro Ferreira

1 August 2007 in Clinics
Verified
Journal Article
Open access
PDF file
JMJose Kleber Kobol Machado
Jose Kleber Kobol Machado
RFRubens Feferbaum
Rubens Feferbaum
CKCelia Etsuco Kobayashi
Celia Etsuco Kobayashi
CSCristina Sancehs
Cristina Sancehs
Silvia Regina Cavani Jorge SantosSilvia Regina Cavani Jorge Santos
Silvia Regina Cavani Jorge Santos
OBJETIVE: The objective of the present study was to evaluate the kinetic disposition of vancomycin in preterm infants with emphasis on the apparent volume of distribution, biological half-life, and total body clearance as well as whether their variations cause significant modification of the trough plasma concentration of the drug, depending on the postconceptional age (PCA) and the postnatal age (PNA). MATERIAL AND METHOD: Twenty-five selected patients were distributed into 2 groups which differed significantly in terms of mean PCA (31.2-32.3 weeks in group 1, n = 13; 33.5-34.1 weeks in group 2, n = 12: CI95%, P < .001) and PNA (group 1, 12.0-18.5 days; group 2, 18.0-34.0 days, CI95%, P < .05). The parents were informed and signed a written consent for participation of the infants in the protocol that had been previously approved by the Ethics Committee of the hospital. RESULTS: Apparent volume of distribution was significantly increased in group 1 compared with patients of group 2 (0.85 vs. 0.56 L/kg, respectively; P = .01,). Additionally multiple linear regression revealed a good linear correlation (r = 0.85) of trough plasma concentration of vancomycin with the apparent volume of distribution and also with the biological half-life in patients of group 1, while a good correlation (r = 0.91) was obtained for the trough plasma concentration with total body clearance in infants of group 2. The influence of these kinetic parameters on the trough concentration of vancomycin in preterm infants seems to vary according to PCA and PNA. CONCLUSION: In conclusion, the trough plasma concentration of vancomycin depends on the pharmacokinetics, and multiple linear correlation indicates that it varies according to the postconceptional and postnatal age of preterm infants.

14 February 2018 in Clinics
Verified
Journal Article
Open access
CSCarlos R. Silva-Filho
Carlos R. Silva-Filho
RBRicardo Antonio G. Barbosa
Ricardo Antonio G. Barbosa
CSCarlindo V. Silva-Jr
Carlindo V. Silva-Jr
LMLuiz M.S. Malbouisson
Luiz M.S. Malbouisson
Maria CarmonaMaria Carmona
Maria Carmona
Silvia Regina Cavani Jorge SantosSilvia Regina Cavani Jorge Santos
Silvia Regina Cavani Jorge Santos
The objective of this study was to apply a pharmacokinetics-pharmacodynamics approach to investigate the free propofol plasma levels in patients undergoing coronary artery bypass grafting under hypothermic conditions compared with the off-pump procedure.Nineteen ...

1 June 2007 in Clinics
Verified
Journal Article
Open access
PDF file
CSCristina Sanches
Cristina Sanches
FGFilomena R.B.G. Galas
Filomena R.B.G. Galas
ASAnne G.O. de M. Silva
Anne G.O. de M. Silva
Maria CarmonaMaria Carmona
Maria Carmona
JAJosé Otavio Auler
José Otavio Auler
Silvia Regina Cavani Jorge SantosSilvia Regina Cavani Jorge Santos
Silvia Regina Cavani Jorge Santos
To evaluate the analytical micromethod using liquid chromatography for the quantification of propranolol in children submitted to surgery of tetralogy of Fallot (TLF). Only 0.2 mL of plasma is required for the assay. Peaks eluted at 8.4 (Propranolol) and 17.5 min (verapamil, internal standard) from a C18 column, with a mobile phase 0.1 M acetate buffer, pH 5.0, and acetonitrile (60:40, v/v) at flow rate 0.7 mL/min, detected at 290 nm (excitation) and 358 nm (emission). Surgery was started 776 min of drug administration (8.7 mg, mean); seven blood samples were collected from six patients (4M/2F; 2.1 yrs;11.5 kg; 0.80 m; 18.9 kg/m(2)). Confidence limits of the method showed high selectivity and recovery, sensitivity of 0.02ng/mL, good linearity (0.05-1000 ng/mL), precision of 8.6% and accuracy of 3.1%. The mean duration of surgery was 283.2 min, with the patients remaining under cardiopulmonary bypass (CPB) for 114 min. A declining curve of propranolol plasma concentration was obtained after the last dose in the night that preceded the day of surgery. Plasma concentration also was normalized with hematocrit due to the hemodilution caused by the CPB procedure. On the other hand a decrease on drug plasma concentration was obtained between periods, the beginning of surgery to the postoperative day 2 (7.09 ng/mL and 0.05 ng/mL, p<0.05 respectively) and from the end of CPB to the postoperative day 2 (2.79 ng/mL e 0.05 ng/mL, p<0.05). Propranolol monitoring of plasma concentrations of children (TLF) normalized after the last preoperative dose revealed a decline from the beginning of surgery to the second postoperative day, suggesting that, once redistribution was restored, propranolol washout was complete.

1 June 2007 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
FLFátima da Silva Leite
Fátima da Silva Leite
LSLuciana Moraes dos Santos
Luciana Moraes dos Santos
WBWanderley Wesley Bonafé
Wanderley Wesley Bonafé
ACAndréia Zago Chignalia
Andréia Zago Chignalia
Maria CarmonaMaria Carmona
Maria Carmona
Silvia Regina Cavani Jorge SantosSilvia Regina Cavani Jorge Santos
Silvia Regina Cavani Jorge Santos
Betablockers are used in the treatment of angina pectoris and others ischemic coronary diseases, reducing mortality and cardiovascular events. Atenolol is a hydrophilic betablocker which is characterized by gastrointestinal absorption, small extent of distribution and renal function-dependent elimination. The study objective was to determine the inter-individual variability of atenolol in coronary patients. Plasma atenolol was quantified in six blood samples collected during the preoperative period from seven patients with coronary insufficiency and surgical indication, chronically treated with atenolol PO 25 to 100 mg/day. All patients presented a normal or slightly reduced renal function. All enrolled patients presented normal or slightly reduced renal function as a result of age and underlying disease. Atenolol plasma concentrations showed a monoexponential decline, confirming the first-order pharmacokinetics at the doses employed for the control of coronary insufficiency (mean +/- SD): 123 +/- 56, 329 +/- 96, 288 +/- 898, 258 +/- 85, 228 +/- 79 and 182 +/- 73 ng/ml at times zero, 2, 4, 6, 8 and 12h after dose administration. The investigated group showed a small inter-patient variability of atenolol administrated at multiple regimens due to the hydrophilic characteristic of the drug. Furthermore, accumulation of atenolol administered chronically was greater in coronary patients, compared to healthy subjects. In view of its cardio-selectivity and low-variability, atenolol should be used as the first-choice drug for the treatment of acute coronary syndrome and other cardiovascular diseases.

1 June 2015 in Brazilian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
Silvia Regina Cavani Jorge SantosSilvia Regina Cavani Jorge Santos
Silvia Regina Cavani Jorge Santos
CSCristina Sancehs
Cristina Sancehs
CJCarlindo Vieira Silva Júnior
Carlindo Vieira Silva Júnior
DGDavid Souza Gomez
David Souza Gomez
A bioanalytical method was developed and applied to quantify the free imipenem concentrations for pharmacokinetics and PK/PD correlation studies of the dose adjustments required to maintain antimicrobial effectiveness in pediatric burn patients. A reverse-phase Supelcosil LC18 column (250 x 4.6 mm 5 micra), binary mobile phase consisting of 0.01 M, pH 7.0 phosphate buffer and acetonitrile (99:1, v/v), flow rate of 0.8 mL/min, was applied. The method showed good absolute recovery (above 90%), good linearity (0.25-100.0 µg/mL, r2=0.999), good sensitivity (LLOQ: 0.25 µg/mL; LLOD: 0.12 µg/mL) and acceptable stability. Inter/intraday precision values were 7.3/5.9%, and mean accuracy was 92.9%. A bioanalytical method was applied to quantify free drug concentrations in children with burns. Six pediatric burn patients (median 7.0 years old, 27.5 kg), normal renal function, and 33% total burn surface area were prospectively investigated; inhalation injuries were present in 4/6 (67%) of the patients. Plasma monitoring and PK assessments were performed using a serial blood sample collection for each set, totaling 10 sets. The PK/PD target attained (40%T>MIC) for each minimum inhibitory concentration (MIC: 0.5, 1.0, 2.0, 4.0 mg/L) occurred at a percentage higher than 80% of the sets investigated and 100% after dose adjustment. In conclusion, the purification of plasma samples using an ultrafiltration technique followed by quantification of imipenem plasma measurements using the LC method is quite simple, useful, and requires small volumes for blood sampling. In addition, a small amount of plasma (0.25 mL) is needed to guarantee drug effectiveness in pediatric burn patients. There is also a low risk of neurotoxicity, which is important because pharmacokinetics are unpredictable in these critical patients with severe hospital infection. Finally, the PK/PD target was attained for imipenem in the control of sepsis in pediatric patients with burns.